During the last week of July, shares of the pharmaceutical producer Slovakofarma a.s., Bratislava were transferred to those quoted at the Bratislava Stock Exchange (BCPB). Investors gave their thumbs up to the shares, with the securities selling at around 4,000 Sk. Quoted companies are obliged to inform the public about all indicators and events which could possibly influence the share price. Slovakofarma's registered assets are divided into 1,384,588 current shares and 138,459 employees shares, with a nominal value of 1,000 Sk per share.
At May's general meeting, shareholders decided to issue a 220 Sk dividend per current share and 230 Sk per employee share. The majority shareholder of the company is the management company, S.L. Pharma Holding, which is registered in Austria and controls 78.1 percent of votes, the rest of the shares being owned by institutional and individual investors. Primary trading will start in September with the issue of new Slovakofarma shares for 93.533 million Sk, a decision taken at a general meeting of the company's shareholders in February. The issue will be managed by Všeobecná Úverová Banka) Bratislava.
